Loading insider details...
Latest Form 4 (Jun 24, 2026): Disposition to Issuer of 62,085 CNTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Centessa Pharmaceuticals plc (CNTA) | Disposition to Issuer | 62,085 | n/a |
| Mar 27, 2026 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 41,076 | $329.0K |
| Mar 18, 2026 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 64,768 | $259.7K |
| Mar 13, 2026 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 109,398 | $438.7K |
| Feb 3, 2026 | Centessa Pharmaceuticals plc (CNTA) | Tax Withholding | 10,606 | $260.6K |
| Feb 10, 2025 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 30,526 | $122.4K |
| Feb 4, 2025 | Centessa Pharmaceuticals plc (CNTA) | Tax Withholding | 10,732 | $181.6K |
| Dec 17, 2024 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 5,876 | $22.6K |
| Mar 26, 2024 | Centessa Pharmaceuticals plc (CNTA) | Exercise/Conversion | 25,010 | $100.3K |
| Feb 2, 2024 | Centessa Pharmaceuticals plc (CNTA) | Grant/Award | 31,250 | n/a |